disease detection News
-
Diagnostics-4-Future Conference
Meet us from October 12 – 13, 2022 at the Diagnostics-4-Future conference in Konstanz and learn more about our know-how in the fields of contract manufacturing, contract development, lifecycle management and many more. Meet LRE Medical at booth #16 or if you would like to set an appointment, please reach out to Claudia Strehle at strehle@lre.de. Diagnostics-4-Future is an ...
By LRE Medical
-
Showcase
Koning Ends the Year with $2.6M Republic Raise
NORCROSS, Ga., Feb. 1, 2022 /PRNewswire/ -- Koning, a growing medical device startup company based outside Atlanta, had a successful conclusion to 2021. The company recently finished their first Republic crowdfunding campaign, exceeding capital targets, and raising over $2.6M in only 5 months. Koning's FDA breast screening trial is also underway with participating clinics in Daytona Beach, FL and ...
-
Showcase
Koning Begins FDA Clinical Screening Trial in Daytona Beach, Florida
DAYTONA BEACH, Fla., Nov. 1, 2021 /PRNewswire/ -- Koning begins an FDA screening trial this month for their no-compression, Isotropic, 3-dimensional breast imaging device. The company received FDA PMA approval for commercial, diagnostic use in 2017. Since then, the Koning Breast CT (KBCT) has been installed in clinics and universities in the US and globally. "This FDA screening trial is a major ...
-
Mammoth Biosciences to Present at 40th Annual J.P. Morgan Healthcare Conference
Mammoth Biosciences, a biotech company building the next generation of CRISPR products to cure and detect disease, today announced its participation in the upcoming 40th Annual J.P. Morgan Healthcare Conference. Mammoth’s co-founder and CEO, Trevor Martin, will present a corporate overview virtually on January 11, 2022 at 1:30 p.m. PT (4:30 p.m. ET). About Mammoth Biosciences Mammoth ...
-
Comprehensive genomic profiling-informed personalized molecular residual disease detection
An exploratory analysis from the PREDATOR study of metastatic colorectal cancer (mCRC) patients undergoing surgicalAuthors (in order): Halla Nimeiri1, Amanda Young1, Russell Madison1, Alexander Fine1, Ole Gjoerup1, Fotios Loupakis2, Matteo Fassan2,3, Sara Lonardi2, Shruti Sharma4, Hsin-Ta Wu4, Alexey Aleshin4, Elise Renkonen1, Priti Hegde11Foundation Medicine Inc, 2Istituto Oncologico Veneto ...
-
Mammoth Biosciences Named as an “Endpoints 11” Most Promising Startup of 2022
Mammoth Biosciences, a biotech company harnessing next-generation CRISPR technology to detect and cure disease, has been chosen by Endpoints News Editor John Carroll as one of the most promising biotech startups for this year’s Endpoints 11 annual special report. Comprising a team of scientist-founders, experienced biopharma veterans, and talented researchers, Mammoth is developing a ...
-
Koning Goes Live on Investment Platform, Republic, With More Milestones to Come
Koning’s Series C fundraise is now available to both accredited and everyday investors via two leading tech investment websites. Atlanta, GA: After launching on Revere on Monday, Koning Corporation has launched a second fundraising campaign on the investment platform Republic. “We’re very excited to be both on Republic and Revere. This is our official first public solicitation ...
-
Alveo Technologies Announces Research Collaboration with Janssen Pharmaceuticals, Inc. to Advance At-Home Testing Platform for Viral Infectious Diseases
Alveo Technologies, a leader in developing novel technologies that enable real-time, low-cost, at-home molecular detection of infectious disease, announced today that it has entered into a research collaboration with Janssen Pharmaceuticals, Inc., (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to advance Alveo’s be.well™ platform of analyzers, nasal ...
-
Alveo Technologies Expands Scientific Advisory Board with Appointment of Esteemed Healthcare Business Executive, Fran Soistman
Alveo Technologies, a leader in developing novel technologies that enable real-time, low-cost, at-home molecular detection of infectious disease, today announced that Fran Soistman has joined the company’s Scientific Advisory Board (SAB). Soistman is an accomplished business executive who has decades of experience driving profitable growth for healthcare entities. As a member of ...
-
Alveo Technologies Expands Leadership Team with Appointment of Julianne Averill as Chief Financial Officer
Alveo Technologies, a leader in developing novel technologies that enable real-time, low-cost, at-home molecular detection of infectious disease, today announced it has appointed Julianne Averill, CPA, as Chief Financial Officer. In this role, Ms. Averill will be responsible for leading all financial operations and implementing key business strategies to accelerate Alveo’s growth as the ...
-
Koning Republic Campaign Reaches New Milestones
Atlanta, GA: A month into Koning’s Republic fundraising campaign, the company has already passed a quarter of a million dollars of investments from 740 investors. “We’re proud of the progress we’ve made on the campaign so far and we’re confident that this positive trajectory will continue”, says Koning’s US CEO, Lutao Ning. “It goes to show how ...
-
Guided Therapeutics Replaces Convertible Note Facility and Significantly Reduces Dilution
Guided Therapeutics, Inc. or the “Company” (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it has raised an additional US $1.13 million under the terms of a 3-year convertible debenture. The proceeds are intended to pay off an existing convertible note that matures at the end of 2021. The convertible ...
-
Koning Announces Partnership to Get Ten Breast CT Devices Installed in Southeast Asia in Time For Breast Cancer Awareness Month
HONG KONG, Oct. 8, 2021 /PRNewswire/ -- Koning Corporation has been working to get more Koning Breast CT (KBCT) into clinics not only throughout the US, but also around the world. Within the past week, the company has entered into a partnership with Chesa Industries LTD with the intention of putting ten KBCT into clinics across Southeast Asia. “This partnership will allow many more women ...
-
Koning Selected as Finalist to Present at Women’s Health Innovation Summit
Boston, MA: Koning has been selected as a finalist to present at the Women’s Health Innovation Summit on September 14, 2021. Of over 100 applicants, Koning is one of only ten companies that has been chosen and will showcase the Koning Breast CT - a technology that will change millions of women’s lives around the world through no compression, low dose, and true 3D imaging. ...
-
Thermo Fisher Scientific Collaborates with Owlstone Medical to Advance the Identification of Novel Biomarkers
Thermo Fisher Scientific, the world leader in serving science, and Owlstone Medical, the global leader in Breath Biopsy for applications in early disease detection and precision medicine, have entered into a collaborative partnership to advance the early diagnosis of cancer and other diseases through the discovery and validation of novel biomarkers by non-invasive breath sampling. Through the ...
-
Guided Therapeutics Announces Testing Completion of First 150 Patients in Chinese Clinical Study and Receives Milestone Payment of $177,740
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that testing of 150 patients has been completed in the ongoing clinical trial for Chinese National Medical Products Administration (NMPA) approval. The trial is underway at four sites in China. The trial is expected to be completed in the second quarter of this year and submitted for approval ...
-
New Insights on AI for Radiology being delivered by CureMetrix at RSNA 2021 Annual Meeting
CureMetrix, Inc., a global healthcare technology company that develops AI-based software for radiology, will present multiple in-person and virtual sessions at the 2021 Radiological Society of North American (RSNA) Scientific Assembly and Annual Meeting, a hybrid event that will take place both online and live at McCormick Place in Chicago, IL, November 28 to December 2, 2021. Notably, at the ...
-
Alfa Chemistry Diversifies Its Chemical Supply by Adding Luminescent Materials, Biomedical Polymers, and Electroplating Intermediates
As an ISO 9001:2015 certified supplier of high-quality chemicals, Alfa Chemistry maintains its commitment and continues to broaden its product lines in the hope of bringing better, quicker, and more cost-efficient chemical solutions for all customers both at home and abroad. Earlier this month, Alfa Chemistry announced the implementation of three types of specialized materials, i.e., luminescent ...
-
Guided Therapeutics Closes $2.114 Million Series F Preferred Stock Financing
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it had closed its Series F Preferred Stock Financing on March 26, 2021. This oversubscribed sale of 2,114 Series F Preferred Shares resulted in gross proceeds to the Company of $2,114,000, netting approximately $1,980,000 after legal costs, ...
-
Mammoth Biosciences Raises $195 Million to Build Next-Generation CRISPR Products in Therapeutics and Diagnostics
Enables expansion of novel CRISPR platform, including proprietary ultra-small Cas14 and Cas? CRISPR systems for in vivo gene-editing therapeutics Makes key appointment of biotech veteran Gary Loeb as general counsel Mammoth Biosciences, the biotech company leveraging the diversity of life to build the next generation of CRISPR products to cure and detect disease, today announced it has ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you